WEST PHARMACEUTICAL SERVICES, INC. (WST) Net margin 2016–2025
WEST PHARMACEUTICAL SERVICES, INC. (WST) net profit margin by fiscal year — reported net income divided by reported revenue.
16.1%FY2025 · since FY2016: 9.5% → 16.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 16.1% | -1.0 pp |
| FY2024 | 17.0% | -3.1 pp |
| FY2023 | 20.1% | -0.2 pp |
| FY2022 | 20.3% | -3.1 pp |
| FY2021 | 23.4% | +7.2 pp |
| FY2020 | 16.1% | +3.0 pp |
| FY2019 | 13.1% | +1.1 pp |
| FY2018 | 12.0% | +2.6 pp |
| FY2017 | 9.4% | -0.1 pp |
| FY2016 | 9.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice